Foyston, Gordon, & Payne Inc - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foyston, Gordon, & Payne Inc ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,048,139
-90.8%
10,290
-90.9%
0.29%
-90.4%
Q2 2023$11,407,068
+322.7%
113,042
+285.4%
2.98%
+311.2%
Q1 2023$2,698,360
-0.9%
29,330
-2.2%
0.73%
-3.5%
Q4 2022$2,721,872
+16.6%
30,003
-2.3%
0.75%
+17.5%
Q3 2022$2,335,000
-13.2%
30,718
+175.0%
0.64%
-17.7%
Q2 2022$2,690,000
-3.2%
11,172
-64.7%
0.78%
+14.2%
Q1 2022$2,780,000
+0.4%
31,680
+0.1%
0.68%
+5.4%
Q4 2021$2,768,000
-21.8%
31,645
-26.9%
0.65%
-26.9%
Q3 2021$3,540,000
-10.9%
43,289
-0.5%
0.88%
-6.4%
Q2 2021$3,971,000
-17.6%
43,519
-22.8%
0.94%
-16.9%
Q1 2021$4,819,000
-10.9%
56,373
-1.5%
1.14%
-13.0%
Q4 2020$5,406,000
+3.1%
57,250
-5.0%
1.30%
-3.5%
Q3 2020$5,243,000
+2.2%
60,289
+2.6%
1.35%
+7.4%
Q2 2020$5,132,000
-11.9%
58,755
-16.8%
1.26%
-16.7%
Q1 2020$5,824,000
-15.1%
70,642
-2.4%
1.51%
+17.1%
Q4 2019$6,857,000
+12.0%
72,413
+2.8%
1.29%
+6.0%
Q3 2019$6,121,000
-16.8%
70,434
-12.6%
1.22%
-11.2%
Q2 2019$7,357,000
-5.0%
80,567
+0.0%
1.37%
-7.2%
Q1 2019$7,744,000
+12.0%
80,544
-0.0%
1.48%
+6.2%
Q4 2018$6,914,000
-8.4%
80,575
-8.0%
1.39%
+8.1%
Q3 2018$7,549,000
+14.9%
87,621
+0.7%
1.29%
+6.4%
Q2 2018$6,570,000
-3.4%
86,976
+3.4%
1.21%
-7.5%
Q1 2018$6,804,000
-4.5%
84,156
-0.8%
1.31%
-3.3%
Q4 2017$7,122,000
-50.5%
84,825
-49.4%
1.36%
-45.8%
Q3 2017$14,399,000
+98.2%
167,723
+92.7%
2.50%
+59.6%
Q2 2017$7,264,000
+10.4%
87,030
-1.8%
1.57%
+10.4%
Q1 2017$6,582,000
-1.1%
88,628
-3.0%
1.42%
-10.2%
Q4 2016$6,657,000
+940.2%
91,395
+1028.3%
1.58%
+1175.0%
Q3 2016$640,000
-4.2%
8,1000.0%0.12%
+1.6%
Q2 2016$668,000
+13.8%
8,1000.0%0.12%
+11.9%
Q1 2016$587,000
-16.5%
8,100
-0.8%
0.11%
-18.0%
Q4 2015$703,000
-6.4%
8,1680.0%0.13%
-5.0%
Q3 2015$751,000
-5.8%
8,168
+0.8%
0.14%
+16.7%
Q2 2015$797,000
-0.3%
8,1000.0%0.12%
+1.7%
Q1 2015$799,000
+6.4%
8,1000.0%0.12%
+10.3%
Q4 2014$751,000
-1.4%
8,1000.0%0.11%
-1.8%
Q3 2014$762,000
+0.7%
8,100
-3.1%
0.11%
+13.5%
Q2 2014$757,000
+6.5%
8,3590.0%0.10%
+9.1%
Q1 2014$711,000
+2.6%
8,359
-3.0%
0.09%
+2.3%
Q4 2013$693,000
+4.8%
8,6190.0%0.09%0.0%
Q3 2013$661,0008,6190.09%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders